References
- Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019 Oct 19;394(10207):1467–1480.
- Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017 Mar;67(2):93–99.
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646–674.
- Siriwardena AK, Mason JM, Mullamitha S, et al. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol. 2014 Aug;11(8):446–459.
- Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019 Nov;20(11):675–691.
- Qu S, Yang X, Li X, et al. Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015 Sep 1;365(2):141–148.
- Chen I, Chen C-Y, Chuang T-J. Biogenesis, identification, and function of exonic circular RNAs. Wiley Interdiscip Rev RNA. 2015 Sep-Oct;6(5):563–579.
- Li XN, Wang ZJ, Ye CX, et al. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018 Dec 27;37(1):325.
- Xu H, Wang C, Song H, et al. RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019 Jan 10;18(1):8.
- Yuan Y, Liu W, Zhang Y, et al. CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression via microRNA-21 and microRNA-31. Biochem Biophys Res Commun. 2018 Sep 5;503(2):870–875.
- Geng Y, Zheng X, Hu W, et al. Hsa_circ_0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expression. Clin Sci (Lond). 2019 May 30;133(10):1197–1213.
- Chen Z, Ren R, Wan D, et al. Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression. Oncogene. 2019 Aug;38(32):6017–6034.
- Chen H, Liang C, Wang X, et al. The prognostic value of circRNAs for gastric cancer: A systematic review and meta-analysis. Cancer Med. 2020;9(23):9096–9106
- Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015 Oct;52(10):710–718.
- Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227.
- Savardashtaki A, Shabaninejad Z, Movahedpour A, et al. miRNAs derived from cancer-associated fibroblasts in colorectal cancer. Epigenomics. 2019;Nov;11(14):1627–1645.
- Yao H, Xia D, Li ZL, et al. miR-382-5p functions as tumor suppressor and chemosensitizer in colorectal cancer. Biosci Rep. 2019 Aug 9;39(8):BSR20180441.
- McGrath SE, Annels N, Madhuri TK, et al. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer. BMC Cancer. 2018 Oct 3;18(1):943.
- Li Y, Liu J, Xiao Q, et al. EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer. Cell Death Dis. 2020 Jul 30;11(7):604.
- Lu J, Zhang PY, Xie JW, et al. Hsa_circ_0000467 promotes cancer progression and serves as a diagnostic and prognostic biomarker for gastric cancer. J Clin Lab Anal. 2019 Mar;33(3):e22726.
- Mo WL, Jiang JT, Zhang L, et al. Circular RNA hsa_circ_0000467 promotes the development of gastric cancer by competitively binding to MicroRNA miR-326-3p. Biomed Res Int. 2020 Feb 6;2020:4030826.
- Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999–3004.
- Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005 Jan 14;120(1):15–20.
- Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016 Jan;28(1):15004.
- Wang J, Chen C, Yan X, et al. The role of miR-382-5p-5p in glioma cell proliferation, migration and invasion. Onco Targets Ther. 2019 Jun 25;12:4993–5002.
- Zhou B, Song J, Han T, et al. miR-382-5p inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer. Mol Carcinog. 2016 Dec;55(12):2260–2267.
- Jin Y, Zhan X, Zhang B, et al. Polydatin exerts an antitumor effect through regulating the miR-382-5p/PD-L1 axis in colorectal cancer. Cancer Biother Radiopharm. 2020 Mar;35(2):83–91.
- Sandberg ES, Calikoglu AS, Loechner KJ, et al. Short stature homeobox-containing haploinsufficiency in seven siblings with short stature. Case Rep Endocrinol. 2017;2017:7287351.
- Lai CY, Pan B, Luo Y, et al. Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma. Mol Biol Rep. 2014;41:3651–3657.
- Lin X, Liu X, Gong C. Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non-small cell lung cancer cells. Oncol Lett. 2018 Jul;16(1):536–542.
- Li T, Yang W, Li M, et al. Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide. Cancer Cell Int. 2020 Mar 2;20:65.
- Zhou YJ, Yang HQ, Xia W, et al. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2. Life Sci. 2017 Dec 1;190:7–14.